Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2021-02-08 21:00:27
Reporting Period:
Accepted Time:
2021-02-08 21:00:27
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1070494 Acadia Pharmaceuticals Inc ACAD Pharmaceutical Preparations (2834) 061376651
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1772518 Elena Ridloff C/o Acadia Pharmaceuticals Inc.
12830 El Camino Real, Suite 400
San Diego CA 92130
Evp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-04 6,490 $0.00 10,391 No 4 A Direct
Common Stock Disposition 2021-02-04 2,051 $50.61 8,340 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
  1. On April 29, 2019, the reporting person was granted Restricted Stock Units (RSU's) that vest upon the Issuer's satisfaction of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the RSU's as to the number of shares reported in column 4 of row 1 above.
  2. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.